Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial

Author:

Paterson Alexander HG,Anderson Stewart J,Lembersky Barry C,Fehrenbacher Louis,Falkson Carla I,King Karen M,Weir Lorna M,Brufsky Adam M,Dakhil Shaker,Lad Thomas,Baez-Diaz Luis,Gralow Julie R,Robidoux André,Perez Edith A,Zheng Ping,Geyer Charles E,Swain Sandra M,Costantino Joseph P,Mamounas Eleftherios P,Wolmark Norman

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials;Lancet,2005

2. Primary breast cancer (PBC) as a risk factor for bone recurrence (BR): NSABP experience;Smith;Proc Am Soc Clin Oncol,1999

3. Effect of systemic adjuvant treatment on first sites of breast cancer relapse;Goldhirsch;Lancet,1994

4. Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease;Fleisch;Drugs,1991

5. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice;Sasaki;Cancer Res,1995

Cited by 167 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3